Literature DB >> 15482592

Novel missense polymorphism in the regulator of G-protein signaling 10 gene: analysis of association with schizophrenia.

Akitoyo Hishimoto1, Osamu Shirakawa, Naoki Nishiguchi, Shinsuke Aoyama, Hisae Ono, Takeshi Hashimoto, Kiyoshi Maeda.   

Abstract

Dysfunction of neuronal signal transduction via G-protein has previously been speculated to be involved in the pathophysiology of schizophrenia. Regulator of G-protein signaling (RGS) is a protein that acts as a GTPase-activator for Galpha protein. A total of 33 Japanese patients with schizophrenia were screened for mutations in the coding region of the RGS10 gene, and a novel missense polymorphism (Val38Met) in the RGS domain was detected. A case-control study did not reveal a significant association between this polymorphism and schizophrenia. The results do not provide evidence that the RGS10 gene is involved in biological vulnerability to schizophrenia.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15482592     DOI: 10.1111/j.1440-1819.2004.01303.x

Source DB:  PubMed          Journal:  Psychiatry Clin Neurosci        ISSN: 1323-1316            Impact factor:   5.188


  9 in total

1.  Age-related changes in regulator of G-protein signaling (RGS)-10 expression in peripheral and central immune cells may influence the risk for age-related degeneration.

Authors:  George T Kannarkat; Jae-Kyung Lee; Chenere P Ramsey; Jaegwon Chung; Jianjun Chang; Isadora Porter; Danielle Oliver; Kennie Shepherd; Malú G Tansey
Journal:  Neurobiol Aging       Date:  2015-02-13       Impact factor: 4.673

Review 2.  Regulator of G protein signaling 10: Structure, expression and functions in cellular physiology and diseases.

Authors:  Faris Almutairi; Jae-Kyung Lee; Balázs Rada
Journal:  Cell Signal       Date:  2020-08-31       Impact factor: 4.315

Review 3.  Genetic Analysis of Rare Human Variants of Regulators of G Protein Signaling Proteins and Their Role in Human Physiology and Disease.

Authors:  Katherine E Squires; Carolina Montañez-Miranda; Rushika R Pandya; Matthew P Torres; John R Hepler
Journal:  Pharmacol Rev       Date:  2018-07       Impact factor: 25.468

4.  Brain RGS4 and RGS10 protein expression in schizophrenia and depression. Effect of drug treatment.

Authors:  G Rivero; A M Gabilondo; J A García-Sevilla; L F Callado; R La Harpe; B Morentin; J J Meana
Journal:  Psychopharmacology (Berl)       Date:  2012-10-24       Impact factor: 4.530

Review 5.  Molecular mechanisms underlying synergistic effects of SSRI-antipsychotic augmentation in treatment of negative symptoms in schizophrenia.

Authors:  Yael Chertkow; Orly Weinreb; Moussa B H Youdim; Henry Silver
Journal:  J Neural Transm (Vienna)       Date:  2009-07-04       Impact factor: 3.575

6.  RGS10 exerts a neuroprotective role through the PKA/c-AMP response-element (CREB) pathway in dopaminergic neuron-like cells.

Authors:  Jae-Kyung Lee; Jaegwon Chung; Kirk M Druey; Malú G Tansey
Journal:  J Neurochem       Date:  2012-05-30       Impact factor: 5.372

7.  Gene-level genome-wide association analysis of suicide attempt, a preliminary study in a psychiatric Mexican population.

Authors:  Thelma Beatriz González-Castro; José Jaime Martínez-Magaña; Carlos Alfonso Tovilla-Zárate; Isela Esther Juárez-Rojop; Emmanuel Sarmiento; Alma Delia Genis-Mendoza; Humberto Nicolini
Journal:  Mol Genet Genomic Med       Date:  2019-10-02       Impact factor: 2.183

8.  Critical role of regulator G-protein signaling 10 (RGS10) in modulating macrophage M1/M2 activation.

Authors:  Jae-Kyung Lee; Jaegwon Chung; George T Kannarkat; Malú G Tansey
Journal:  PLoS One       Date:  2013-11-21       Impact factor: 3.240

9.  The First Pilot Genome-Wide Gene-Environment Study of Depression in the Japanese Population.

Authors:  Takeshi Otowa; Yoshiya Kawamura; Akizumi Tsutsumi; Norito Kawakami; Chiemi Kan; Takafumi Shimada; Tadashi Umekage; Kiyoto Kasai; Katsushi Tokunaga; Tsukasa Sasaki
Journal:  PLoS One       Date:  2016-08-16       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.